Alnylam Pharmaceuticals shares owned by Bellevue Group
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Bellevue Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $223M | 809k | 275.03 |
| 2024-06-30 | $224M | 920k | 243.00 |
| 2024-03-31 | $137M | 918k | 149.45 |
| 2023-12-31 | $170M | 885k | 191.41 |
| 2023-09-30 | $158M | 894k | 177.10 |
| 2023-06-30 | $171M | 900k | 189.94 |
| 2023-03-31 | $177M | 883k | 200.32 |
| 2022-12-31 | $219M | 921k | 237.65 |
| 2022-09-30 | $192M | 957k | 200.16 |
| 2022-06-30 | $154M | 1.1M | 145.85 |
| 2022-03-31 | $201M | 1.2M | 163.29 |
| 2021-12-31 | $226M | 1.3M | 169.58 |
| 2021-09-30 | $266M | 1.4M | 188.82 |
| 2021-06-30 | $263M | 1.5M | 169.53 |
| 2021-03-31 | $230M | 1.6M | 141.19 |
| 2020-12-31 | $208M | 1.6M | 129.97 |
| 2020-09-30 | $227M | 1.6M | 145.61 |
| 2020-06-30 | $239M | 1.6M | 148.11 |
| 2020-03-31 | $193M | 1.8M | 108.85 |
| 2019-12-31 | $215M | 1.9M | 115.17 |
| 2019-09-30 | $158M | 2.0M | 80.42 |
| 2019-06-30 | $140M | 1.9M | 72.56 |
| 2019-03-31 | $25M | 267k | 93.45 |
| 2018-12-31 | $16M | 224k | 72.91 |
| 2018-09-30 | $19M | 220k | 87.52 |
| 2018-06-30 | $10M | 104k | 98.49 |
| 2018-03-31 | $2.6M | 22k | 119.08 |
| 2017-12-31 | $2.8M | 22k | 127.06 |
| 2017-09-30 | $8.9M | 76k | 117.44 |
| 2017-06-30 | $10M | 125k | 79.76 |
| 2017-03-31 | $7.3M | 142k | 51.25 |
| 2016-12-31 | $899k | 24k | 37.46 |
| 2016-09-30 | $1.6M | 24k | 67.79 |
| 2016-06-30 | $1.3M | 24k | 55.50 |
| 2016-03-31 | $1.5M | 24k | 62.75 |